Manager, In Vivo Research and Development , Horizon Discovery
BIOGRAPHY
MAY 22, 2018 8:00 AM PDT
Drug development with nuclear receptor knockout and humanized rat models
Sponsored by: Horizon Discovery
Speakers
-
Andrew Brown, MS
Product Manager, In Vivo, Horizon DiscoveryBIOGRAPHY
Event Date & Time
DATE: May 22, 2018
TIME: 08:00AM PDT
Abstract
The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that regulate the expression of Phase I (Cytochrome P450s), Phase II drug metabolizing enzymes and drug transporter genes in response to stimulation from xenobiotics including prescription drugs . PXR and CAR knockout and humanized mouse models have proven useful. However, the rat being bigger in size, is a preferred model system for studying drug metabolism and pharmacokinetics. Here, we report the creation and preliminary characterization of PXR and CAR knockout rats and PXR/CAR double knockout rats. Whereas the expression of phase I and II enzymes and transporter genes were not upregulated by nuclear receptor-specific agonists in the knockout rats, confirming the disruption of respective nuclear receptor(s). Our data demonstrate that PXR appears to suppress the basal expression levels of specific drug metabolism genes, while CAR maintains and suppresses other drug metabolism genes. Overall, our findings are in good agreement with data obtained from human primary hepatocytes, nuclear receptor knock-out cell lines and mouse knock-out models. We believe these models are a useful complement to their mouse counterparts for drug development and as importantly, for functional studies on metabolic pathways involving nuclear receptors.
Learning Objectives:
- Understand the benefit of rat models versus mouse models in functional studies on metabolic pathways
- Demonstrate the utility of the PXR and CAR KO rat models
- How rat hepatocytes can add value to drug development studies
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Speaker:
Claudia Chiocchini
Presented at: Cancer Research & Oncology Virtual Event Series 2024
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
MAY 22, 2018 8:00 AM PDT
Share
Drug development with nuclear receptor knockout and humanized rat models
Sponsored by: Horizon Discovery
Loading Comments...
Please update your information
Certificate of Attendance
Thank you for choosing Labroots. Please note that a Certificate of Attendance does NOT count towards Continuing Education Credits.
DOWNLOAD CERTIFICATE
DOWNLOAD CERTIFICATE
You must watch the entire webinar to receive your certificate of attendance.
You must attend the event before receiving your certificate of attendance.
You must register for the event first.
Certificate is no longer available for this event.
You must be logged in to retrieve your certificate.